AI technologies have changed daily life for provider organizations and industry partners alike. Arguably the biggest single difficulty to emerge from the complex transformation is the risk of cybersecurity breaches. 

The recall is officially an early alert, as the syringes are part of surgical convenience kits—the rest of which are safe to use. The defective syringes risk causing fatal injuries to patients and must be discarded. 

The maker of popular GLP-1 agonists Wegovy and Ozempic said technology from OpenAI, the company behind ChatGPT, will allow it to sift through and make sense of massive datasets to identify potential new uses for its diabetes and obesity treatments.

MGMA says Trump’s immigration policy combined with Congress’s unwillingness to fund additional medical residency positions is a primary driver accelerating the growing U.S. healthcare staffing shortage.

Almost 15% of more than 5,500 U.S. adults—representing around 14 million individuals—have skipped a doctor visit after feeling satisfied enough with health advice they received from AI.

Demonstrated cost-effectiveness is a highly motivating factor in getting healthcare workers to adopt measures for preventing and controlling healthcare-associated infections.

Prosecutors allege that a licensed therapist in Georgia was working with co-conspirators to bill insurers for sessions that never happened, in exchange for kickbacks. In some cases, more than 24 hours of services were billed in a single day.

Issues in dispute between the University of California and AFSCME Local 3299 include wage increases, insurance costs and access to housing programs. Union officials claim members are experiencing high rates of homelessness, fueled by rising cost of living in California.

The new agentic program, called “Avery,” is now available to millions of UnitedHealthcare members through insurer's existing app. The company said the model will help patients find providers, understand their benefits, get updates on claims and more.

In total, 131 hospitals are acting as plaintiffs. They’re asking a court to throw out 2023 changes to the Disproportionate Share Hospital calculation that altered the way Medicare Advantage and Social Security income were factored into the risk-adjusted payments hospitals receive for caring for vulnerable patient populations.

Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.

"This case reflects a troubling pattern in which payers, dissatisfied with IDR results, increasingly try to attack those outcomes outside the framework Congress created," Rad Partners says.